Drug Type Recombinant polypeptide |
Synonyms P 113L, P-113L, PAC 113 + [1] |
Target |
Mechanism Reactive oxygen species stimulants, Cell membrane permeability enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Candidiasis | Phase 2 | TW | - | 22 Jul 2016 |
Candidiasis, Oral | Phase 2 | US | 01 Jan 2008 | |
Gingivitis | Phase 2 | US | - | |
Mucositis | Preclinical | US | - |